{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:28:23Z","timestamp":1777670903290,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.anndiagpath.2020.151633","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T11:34:55Z","timestamp":1600428895000},"page":"151633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients"],"prefix":"10.1016","volume":"49","author":[{"given":"Linfang","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151633_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.anndiagpath.2020.151633_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1759-7714.12169","article-title":"The epidemiology of lung cancer in China","volume":"6","author":"Chen","year":"2014","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151633_bb0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40880-015-0001-2","article-title":"Annual report on status of cancer in China, 2011","volume":"27","author":"Chen","year":"2015","journal-title":"Chin J Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/annonc\/mdv270","article-title":"First-line erlotinib versus gemcitabine\/cisplatin inpatients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study","volume":"26","author":"Wu","year":"2015","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151633_bb0035","first-page":"2892","article-title":"EGFR mutation incidence in non-small-cell lung cancer of adenocarcinoma histology: a systematic review and global map by ethnicity (mutMapII)","volume":"5","author":"Midha","year":"2015","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0040","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1378\/chest.12-2679","article-title":"Comprehensive analysis of oncogenic mutations in lung squamous cell carcinoma with minor glandular component","volume":"145","author":"Pan","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143515","article-title":"Molecular epidemiology of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology - mainland China subset analysis of the PIONEER study","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0050","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1200\/JCO.2010.32.6181","article-title":"Incidence of EGFR exon 19 deletions and L858Rin tumor specimens from men and cigarette smokers with lung adenocarcinomas","volume":"29","author":"D\u2019Angelo","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0055","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/1759-7714.12859","article-title":"Real world EGFR testing in patients with stage IIIB\/IV non-small-cell lung cancer in North China: a multicenter, non-interventional study","volume":"9","author":"Cheng","year":"2018","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.5301\/jbm.5000177","article-title":"Clinical evaluation and therapeutic monitoring value of serum tum or markers in lung cancer","volume":"31","author":"Wang","year":"2016","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bjc.2017.45","article-title":"et al. Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis","volume":"116","author":"Holdenrieder","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2019.10.005","article-title":"Value of serum tumor markers for predicting EGFR mutations and positive ALK expression in 1089 Chinese non-small-cell lung cancer patients: a retrospective analysis","volume":"124","author":"Wang","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0075","doi-asserted-by":"crossref","first-page":"8863","DOI":"10.2147\/OTT.S225760","article-title":"Clinicopathological characteristics and EGFR-TKIs efficacies in lung squamous cell carcinoma patients harboring an EGFR sensitizing mutation","volume":"12","author":"Zhou","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.anndiagpath.2020.151633_bb0080","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.anndiagpath.2020.151633_bb0085","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1164\/rccm.201702-0433CI","article-title":"AJRCCM: 100-year anniversary. The shifting landscape for lung cancer: past, present, and future","volume":"195","author":"Vachani","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151633_bb0090","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.6004\/jnccn.2018.0078","article-title":"Survivorship, version 2.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Denlinger","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151633_bb0095","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cncr.21238","article-title":"Pro-gastrin\u2013releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation","volume":"104","author":"Yonemori","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0100","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1850::AID-CNCR6>3.0.CO;2-R","article-title":"Evaluation of tissue polypeptide specific antigen, CYFRA21\u20131, and carcinoembryonic antigen in nonsmall cell lung carcinoma: does the combined use of cytokeratin markers give any additional information?","volume":"82","author":"Nisman","year":"1998","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151633_bb0105","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I","article-title":"Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma","volume":"40","author":"Kato","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/1097-0142(19901001)66:7<1505::AID-CNCR2820660712>3.0.CO;2-V","article-title":"Tumor-antigen 4.Its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus","volume":"66","author":"Mino-Miyagawa","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/030089168807400218","article-title":"Prognostic value of squamous cell carcinoma antigen in patients with uterine cervical carcinoma","volume":"74","author":"Bhatavdekar","year":"1988","journal-title":"Tumori"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12885-016-2251-z","article-title":"Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer","volume":"16","author":"Cho","year":"2016","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151633_bb0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/bjc.2016.7","article-title":"New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer","volume":"114","author":"Nisman","year":"2016","journal-title":"Br J Cancer"},{"issue":"S17","key":"10.1016\/j.anndiagpath.2020.151633_bb0130","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1002\/cncr.29551","article-title":"Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients","volume":"121","author":"Yang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000077724","article-title":"Pro-gastrin-releasing peptide in patients with benign and malignant diseases","volume":"25","author":"Molina","year":"2004","journal-title":"Tumour Biol"},{"key":"10.1016\/j.anndiagpath.2020.151633_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000090151","article-title":"The prognostic significance of circulating neuroendocrine markers chromogranina, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer","volume":"27","author":"Nisman","year":"2006","journal-title":"Tumour Biol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2020.151633_bb0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1593\/neo.04454","article-title":"Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cell","volume":"7","author":"Thomas","year":"2005","journal-title":"Neoplasia"},{"issue":"10","key":"10.1016\/j.anndiagpath.2020.151633_bb0150","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","article-title":"Screening for epidermal growth factor receptor mutations in lung cancer","volume":"361","author":"Rosell","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420301799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:30Z","timestamp":1761078810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420301799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":30,"alternative-id":["S1092913420301799"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151633","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of serum tumor markers for predicting EGFR mutations in non-small cell lung cancer patients","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151633"}}